Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1261 of 5804
-
Can a second RSV shot in pregnancy protect more babies?
Disease control Recruiting nowThis study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug aims to tame tumor-triggered low blood sugar in rare cancer patients
Disease control Recruiting nowThe objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug as add-on to standard of care (SOC) therapy for treatment of hypoglycemia in patients with Tumor Hyperinsulinism (Tumor HI).
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Heart-Lung hope: new drug sotatercept tested for tough hypertension
Disease control OngoingResearchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH that is caused by heart failure with preserved ejection fraction (HFpEF). Resea…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Robot or scalpel? new trial tests safer surgery for endometriosis sufferers
Symptom relief Recruiting nowThe purpose of this study is to compare the robot-assisted approach with the laparoscopic approach in terms of reducing the rates of intraoperative and postoperative complications in patients undergoing total hysterectomy for DIE and adenomyosis without digestive tract involvemen…
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
MRNA shot takes on MS: moderna launches brain lesion trial
Disease control Recruiting nowThe primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis.
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New tests aim to outsmart superbug gonorrhea
Diagnosis Recruiting nowThe goal of this study is to learn if a few investigational tests can correctly find the gene mutation (mutant allele gyrA 91F) that predicts ciprofloxacin resistance in clinical specimens that harbor Neisseria gonorrhoeae. The main question the study aims to answer: Can the inv…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
Exercise and sleep coaching show promise for children with autism
Symptom relief Recruiting nowAutism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by impairments in social interaction and communication. Children with ASD frequently experience co-occurring behavioral problems, among which sleep disturbances are highly prevalent, affecting approxim…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could a simple nerve zap boost stroke rehab?
Symptom relief Recruiting nowTo evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Could a shot of your own blood beat botox for bladder control?
Disease control Recruiting nowOveractive bladder is a common condition that causes sudden urges to urinate, frequent urination, night-time urination, and sometimes leakage of urine. Many people with overactive bladder improve with lifestyle changes and medicines. However, some patients do not respond to these…
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jun 26, 2026 18:47 UTC
-
New drug duo targets Hard-to-Treat cancers
Disease control Recruiting nowThe primary objective of this study is to determine the recommended Phase 2 doses (RP2D(s)) and maximum tolerated dose (MTD) of PYX-201 in combination with pembrolizumab for participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a vacuum dressing stop wound infections after breast cancer surgery?
Disease control Recruiting nowThere is little scientific data concerning the use of negative pressure therapy after immediate breast reconstruction. That strategy of treatment-reconstruction has expanded increasingly since the last years. The current literature reports only 3 studies on the use of preventiv…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New heart procedure aims to zap AFib safely
Disease control OngoingThe purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the FARAPULSE catheter system (FARAWAVE catheter used in combination with the FARASTAR generator), to treat patients with atrial fibrillation during clinically-indicated ablation proce…
Phase: PHASE4 • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a Low-Dose immunotherapy boost chemo for hodgkin lymphoma?
Disease control Recruiting nowThe aim of the current trial is to evaluate the efficacy and safety of flat-dose nivolumab (40 mg) in combination with AVD in the management of patients with newly diagnosed advanced classic Hodgkin Lymphoma
Phase: PHASE2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Ultrasound could replace colonoscopies for Crohn's patients on new drug
Knowledge-focused OngoingCrohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can highly alter patients' quality of life and lead to bowel damage due to its transmural pattern. The current guidelines recommend to use treat-to-target strategies to achieve the combination of steroid-free…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New app and coaching aim to help minorities manage chronic pain without pills
Symptom relief Recruiting nowINSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Magnetic heart scan could spot hidden chest pain causes
Diagnosis Recruiting nowThe aim of this prospective study is to identify Non-Obstructive Myocardial Ischemia of patients who have acute chest pain using Magnetocardiography.
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Could HIV drugs help fight brain cancer? new trial launches
Disease control Recruiting nowThe purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed surgically change as a result of the study treatment; and to identify and evaluate the potential side effects (good and bad) of the study treatment in patients with newly…
Phase: PHASE1 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Gene-Guided dosing may tame dangerous fungal infections in blood cancer
Disease control Recruiting nowThis project aims to address invasive fungal infections in patients, by precision dosing of voriconazole based on CYP2C19 genotype testing with Bayesian dose-forecasting dosing software to develop patient-centric and maximally effective dosing regimens. This study investigates if…
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Text messages tailored for american indian smokers could boost quit rates
Disease control Recruiting nowThe aim of this clinical trial is to test the efficacy of a culturally aligned digital smoking cessation resource for American Indian persons who smoke, via a remotely conducted randomized controlled trial.
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Blood test may spare some transplant patients from chemo
Disease control Recruiting nowThe purpose of this study is to find out if there is a benefit to giving rituximab with etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (R-EPOCH) in participants who have high-risk B-cell PTLD in their 2nd phase of treatment (consolidation) while those with l…
Phase: PHASE2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC